8-K Announcements
6Material company update
Feb 23, 2026·SEC
Material company update
Jan 16, 2026·SEC
Material company update
Jan 16, 2026·SEC
Sharps Technology, Inc.(STSS)Earnings, Financials & Key Ratios
STSS•NASDAQ
Price updated Jun 19, 2026
AboutSharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.Show more
- Revenue$204K
- EBITDA-$13M-85.8%
- Net Income-$283M-2938.9%
- EPS (Diluted)-11.16+99.5%
- Gross Margin-202.49%
- EBITDA Margin-6447.16%
- Operating Margin-6512.09%
- Net Margin-138400.02%
- ROE-212.11%-13.3%
STSS Key Insights
Sharps Technology, Inc. (STSS) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗Profits declining 160.7% over 5 years
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 6 (bottom 6%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when STSS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
STSS Price & Volume
Sharps Technology, Inc. (STSS) stock price & volume — 10-year historical chart
Loading chart...
STSS Growth Metrics
Sharps Technology, Inc. (STSS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-5705.35%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM99.5%
Return on Capital
10 Years-160.38%
5 Years-116.43%
3 Years-92.21%
Last Year-9.98%
STSS Peer Comparison
Sharps Technology, Inc. (STSS) competitors in Drug delivery and infusion consumables — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 NNBR | 147.24M | 2.79 | -2.61 | -9.06% | -8.03% | -22.93% | 1.44 | |
 MMSI | 4.01B | 67.22 | 31.56 | 11.66% | 9.03% | 8.95% | 0.57 | |
 NXRT | 684.45M | 26.97 | -21.40 | -3.24% | -12.67% | -10.13% | 5.18 | |
 SRTS | 45.93M | 2.79 | -5.94 | -34.26% | -34.5% | -15.79% | 0.01 | |
 BDX | 52.16B | 143.98 | 24.70 | 8.23% | 5.33% | 4.54% | 0.76 | |
 NVO | 191.93B | 43.19 | 12.18 | 6.43% | 37.2% | 66.36% | 0.67 | |
 ISRG | 144.48B | 406.78 | 51.69 | 20.51% | 28.15% | 16.89% | 0.02 | |
 ICU | 122.25M | 3.12 | -0.53 | 8.14% | -8.29% | -146.29% | 0.05 |
Compare STSS vs Peers
Sharps Technology, Inc. (STSS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
STSS Income Statement
Sharps Technology, Inc. (STSS) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 204.12K | 396.9K |
Revenue Growth % | - | - | - | - | - | - | - | - |
Cost of Goods Sold | 10.59K | 11.04K | 28.7K | 654.57K | 891.25K | 773.9K | 617.45K | 820.02K |
COGS % of Revenue | - | - | - | - | - | - | 302.49% | - |
Gross Profit | -10.59K▲ 0% | -11.04K▼ 4.3% | -28.7K▼ 160.0% | -654.57K▼ 2180.8% | -891.25K▼ 36.2% | -773.9K▲ 13.2% | -413.32K▲ 46.6% | -423.12K▲ 0% |
Gross Margin % | - | - | - | - | - | - | -202.49% | -106.61% |
Gross Profit Growth % | - | -4.26% | -160% | -2180.82% | -36.16% | 13.17% | 46.59% | - |
Operating Expenses | 2.05M | 2.32M | 4.47M | 8.08M | 9.24M | 7.08M | 12.88M | 15.41M |
OpEx % of Revenue | - | - | - | - | - | - | 6309.6% | - |
Selling, General & Admin | 1.66M | 1.51M | 2.78M | 6.45M | 8.52M | 7.14M | 19.49M | 25.1M |
SG&A % of Revenue | - | - | - | - | - | - | 9546.05% | - |
Research & Development | 388.02K | 827K | 1.69M | 1.63M | 729.48K | -58.02K | 198.76K | 319.38K |
R&D % of Revenue | - | - | - | - | - | - | 97.38% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | -15.18K | 0 | -6.81M | -3M |
Operating Income | -2.06M▲ 0% | -2.33M▼ 13.3% | -4.5M▼ 92.7% | -8.74M▼ 94.3% | -10.13M▼ 15.9% | -7.86M▲ 22.4% | -13.29M▼ 69.2% | -15.84M▲ 0% |
Operating Margin % | - | - | - | - | - | - | -6512.09% | -3990.13% |
Operating Income Growth % | - | -13.32% | -92.75% | -94.3% | -15.88% | 22.42% | -69.19% | - |
EBITDA | -2.05M | -2.32M | -4.47M | -8.08M | -9.24M | -7.08M | -13.16M | -15.81M |
EBITDA Margin % | - | - | - | - | - | - | -6447.16% | -3984.09% |
EBITDA Growth % | - | -13.37% | -92.43% | -80.9% | -14.24% | 23.31% | -85.8% | -115.88% |
D&A (Non-Cash Add-back) | 10.59K | 11.04K | 28.7K | 654.57K | 891.25K | 773.9K | 132.54K | 23.95K |
EBIT | -2.06M | -2.34M | -4.5M | -3.32M | -9.87M | -7.62M | -269.92M | -272.46M |
Net Interest Income | 3.6K | 3.33K | -166.75K | -1.32M | 138.12K | -1.66M | -416.66K | 44.89K |
Interest Income | 3.6K | 3.33K | 769 | 1.32K | 138.12K | 40.3K | 0 | 165.44K |
Interest Expense | 0 | 0 | 167.51K | 1.32M | 0 | 1.71M | 416.66K | 120.55K |
Other Income/Expense | 3.6K | -6.87K | -166.75K | 4.1M | 255.01K | -1.47M | -257.04M | -342.67M |
Pretax Income | -2.06M▲ 0% | -2.34M▼ 13.9% | -4.66M▼ 99.3% | -4.64M▲ 0.5% | -9.87M▼ 112.8% | -9.33M▲ 5.5% | -270.34M▼ 2798.7% | -358.5M▲ 0% |
Pretax Margin % | - | - | - | - | - | - | -132439.46% | -90325.9% |
Income Tax | 0 | 0 | 0 | 0 | -30K | -30K | 0 | 0 |
Effective Tax Rate % | 0% | 0% | 0% | 0% | 0.3% | 0.32% | 0% | 0% |
Net Income | -2.06M▲ 0% | -2.35M▼ 14.2% | -4.66M▼ 98.7% | -4.64M▲ 0.5% | -9.84M▼ 112.1% | -9.3M▲ 5.5% | -282.5M▼ 2938.9% | -370.67M▲ 0% |
Net Margin % | - | - | - | - | - | - | -138400.02% | -93391.33% |
Net Income Growth % | - | -14.19% | -98.73% | 0.53% | -112.12% | 5.54% | -2938.9% | -5705.35% |
Net Income (Continuing) | -2.06M | -2.34M | -4.66M | -4.64M | -9.84M | -9.3M | -270.34M | -358.5M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -12.17M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1479.06▲ 0% | -1683.99▼ 13.9% | -3356.30▼ 99.3% | -3780.28▼ 12.6% | -4983.99▼ 31.8% | -2220.05▲ 55.5% | -11.16▲ 99.5% | -5.11▲ 0% |
EPS Growth % | - | -13.86% | -99.31% | -12.63% | -31.84% | 55.46% | 99.5% | 99.5% |
EPS (Basic) | -1479.06 | -1683.99 | -3356.30 | -3780.28 | -4983.99 | -2220.05 | -11.16 | - |
Diluted Shares Outstanding | 1.39K | 1.39K | 1.39K | 1.23K | 1.97K | 4.19K | 25.31M | 72.57M |
Basic Shares Outstanding | 1.39K | 1.39K | 1.39K | 1.23K | 1.97K | 4.19K | 25.31M | 72.57M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
STSS Balance Sheet
Sharps Technology, Inc. (STSS) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 635.5K | 1.84M | 1.61M | 4.42M | 4.84M | 3.17M | 11.23M | 18.38M |
Cash & Short-Term Investments | 635.5K | 1.79M | 1.48M | 4.17M | 3.01M | 864.04K | 10.38M | 12.32M |
Cash Only | 635.5K | 1.79M | 1.48M | 4.17M | 3.01M | 864.04K | 10.38M | 12.32M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 0 | 0 | 0 | 0 | 47.95K | 102.49K | 711.96K | 396.9K |
Days Sales Outstanding | - | - | - | - | - | - | 1.27K | 693.72 |
Inventory | 0 | 0 | 121.99K | 185.8K | 1.71M | 1.87M | 645.27K | 457.71K |
Days Inventory Outstanding | - | - | 1.55K | 103.61 | 699.96 | 880.86 | 381.45 | 387.25 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 | 250K | -7.17M | 5.21M |
Total Non-Current Assets | 25.9K | 391.87K | 4.29M | 7.42M | 6.95M | 4.14M | 81.17K | 162.62M |
Property, Plant & Equipment | 25.9K | 316.87K | 3.76M | 7.34M | 6.82M | 4.04M | 81.17K | 58.83K |
Fixed Asset Turnover | - | - | - | - | - | - | 2.51x | 0.34x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 0 | 0 | 0 | 62.48K | 52.51K | 32.5K | 250.11M | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 404.2M |
Other Non-Current Assets | 0 | 75K | 529.86K | 12.37K | 76.06K | 72.2K | -250.11M | 162.56M |
Total Assets | 661.4K▲ 0% | 2.23M▲ 237.5% | 5.9M▲ 164.4% | 11.84M▲ 100.6% | 11.79M▼ 0.4% | 7.31M▼ 38.0% | 269.08M▲ 3579.0% | 181M▲ 0% |
Asset Turnover | - | - | - | - | - | - | 0.00x | 0.00x |
Asset Growth % | - | 237.47% | 164.43% | 100.59% | -0.43% | -37.96% | 3579.03% | 8352.87% |
Total Current Liabilities | 100.49K | 101.25K | 2.77M | 2.01M | 3.69M | 5.19M | 4.7M | 2.22M |
Accounts Payable | 100.49K | 101.25K | 804.14K | 543.23K | 794.11K | 976.55K | 590.69K | 1.58M |
Days Payables Outstanding | 3.46K | 3.35K | 10.23K | 302.91 | 325.22 | 460.57 | 349.19 | 534.07 |
Short-Term Debt | 0 | 0 | 700.01K | 0 | 0 | 3.76M | 3.08M | 0 |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 585K | 1.15M | 2.42M | 98.91K | 1.02M | 637.73K |
Current Ratio | 6.32x | 18.18x | 0.58x | 2.20x | 1.31x | 0.61x | 2.39x | 8.28x |
Quick Ratio | 6.32x | 18.18x | 0.54x | 2.11x | 0.85x | 0.25x | 2.25x | 8.08x |
Cash Conversion Cycle | - | - | - | - | - | - | 1.31K | 546.9 |
Total Non-Current Liabilities | 0 | 0 | 0 | 192K | 162K | 132K | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities | 0 | 0 | 0 | 192K | 162K | 132K | 0 | 264K |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 100.49K | 101.25K | 2.77M | 2.2M | 3.85M | 5.32M | 4.7M | 2.22M |
Total Debt | 0 | 0 | 700.01K | 0 | 0 | 3.76M | 3.08M | 0 |
Net Debt | -635.5K | -1.79M | -779.15K | -4.17M | -3.01M | 2.9M | -7.3M | -12.32M |
Debt / Equity | - | - | 0.22x | - | - | 1.89x | 0.01x | 0.00x |
Debt / EBITDA | - | - | - | - | - | - | - | -0.00x |
Net Debt / EBITDA | - | - | - | - | - | - | - | 0.78x |
Interest Coverage | - | - | -26.84x | -2.51x | - | -4.47x | -647.82x | -2260.15x |
Total Equity | 560.92K▲ 0% | 2.13M▲ 279.9% | 3.14M▲ 47.2% | 9.64M▲ 207.4% | 7.93M▼ 17.7% | 2M▼ 74.8% | 264.38M▲ 13144.6% | 178.78M▲ 0% |
Equity Growth % | - | 279.88% | 47.18% | 207.41% | -17.7% | -74.84% | 13144.64% | 21469.05% |
Book Value per Share | 403.83 | 1534.07 | 2257.88 | 7857.48 | 4019.40 | 476.74 | 10.45 | 2.46 |
Total Shareholders' Equity | 560.92K | 2.13M | 3.14M | 9.64M | 7.93M | 2M | 264.38M | 178.78M |
Common Stock | 1.38K | 460 | 519 | 941 | 1.53K | 205 | 2.9K | 4.03K |
Retained Earnings | -3.66M | -6M | -10.67M | -15.31M | -25.15M | -34.45M | -316.95M | -403.19M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 214.25K | 591.81K | 23.29K | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
STSS Cash Flow Statement
Sharps Technology, Inc. (STSS) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -1.57M | -1.88M | -3.15M | -6.43M | -8.51M | -6.93M | -16.72M | -16.95M |
Operating CF Margin % | - | - | - | - | - | - | -8190.68% | - |
Operating CF Growth % | - | -19.66% | -67.16% | -104.37% | -32.24% | 18.55% | -141.27% | -558.09% |
Net Income | -2.06M | -2.34M | -4.66M | -4.64M | -9.84M | -9.3M | -270.34M | -370.67M |
Depreciation & Amortization | 10.59K | 11.04K | 28.7K | 654.57K | 882.18K | 773.9K | 132.54K | 23.95K |
Stock-Based Compensation | 400 | 485.2K | 1.2M | 1.01M | 963.02K | 520.83K | 107.47M | 107.42M |
Deferred Taxes | 25.84K | 0 | 0 | 0 | -30K | -30K | 0 | 0 |
Other Non-Cash Items | 372.57K | 10.2K | 179.51K | -3.25M | 639.99K | 1.53M | 143.23M | 227.9M |
Working Capital Changes | 72.42K | -49.24K | 112.64K | -209.22K | -1.12M | -426.18K | 2.79M | 6.21M |
Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | -204.12K | -195.91K |
Change in Inventory | 0 | 0 | -121.99K | -34.11K | -1.44M | -350.56K | -298.24K | -19.68K |
Change in Payables | 47.42K | 759 | 202.89K | -104.35K | 415.51K | 11.94K | 238.45K | 918.02K |
Cash from Investing | -11.18K | -387.2K | -2.34M | -3.12M | -698.28K | -1.16M | -189.16M | -179.4M |
Capital Expenditures | -11.18K | -312.2K | -2.27M | -752.34K | -698.28K | -138.8K | 0 | 90.41K |
CapEx % of Revenue | - | - | - | - | - | - | 0% | 22.78% |
Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 0 | -75K | -75K | -2.16M | 0 | -1.02M | -1.64M | -178.07M |
Cash from Financing | 1.83M | 3.42M | 5.18M | 12.24M | 8.03M | 5.91M | 215.51M | 196.88M |
Debt Issued (Net) | 0 | 0 | 1.8M | -2M | 0 | 2.53M | 3.41M | 4.54M |
Equity Issued (Net) | 1.66M | 3.42M | 3.38M | 14.2M | 8.03M | 3.37M | 212.1M | 192.34M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -162.5K | 0 | 0 | 0 | 0 | 0 | 0 | -1.59M |
Other Financing | 180K | 0 | 0 | 32.5K | 0 | 0 | 0 | 0 |
Net Change in Cash | 636▲ 0% | 1.15M▲ 181456.9% | -311.04K▼ 126.9% | 2.69M▲ 965.4% | -1.16M▼ 143.0% | -2.15M▼ 85.6% | 9.38M▲ 536.4% | 336.9K▲ 0% |
Free Cash Flow | -1.58M▲ 0% | -2.2M▼ 38.5% | -5.42M▼ 146.7% | -7.19M▼ 32.7% | -9.21M▼ 28.1% | -7.07M▲ 23.2% | -16.72M▼ 136.5% | -202.96M▲ 0% |
FCF Margin % | - | - | - | - | - | - | -8190.68% | -51136.1% |
FCF Growth % | - | -38.52% | -146.73% | -32.66% | -28.11% | 23.22% | -136.53% | -2529.98% |
FCF per Share | -1141.02 | -1580.49 | -3899.54 | -5856.15 | -4663.41 | -1688.17 | -0.66 | -2.80 |
FCF Conversion (FCF/Net Income) | 0.77x | 0.80x | 0.67x | 1.39x | 0.86x | 0.75x | 0.06x | 0.55x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -875K |
Taxes Paid | 0 | 1.13K | 0 | 0 | 0 | 0 | 0 | 0 |
STSS Key Ratios
Sharps Technology, Inc. (STSS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -174.4% | -177.12% | -72.62% | -111.99% | -187.23% | -212.11% | -166.42% |
Return on Invested Capital (ROIC) | -1315.65% | -250.09% | -167.47% | -146.18% | -120.05% | -7.61% | -5.53% |
Gross Margin | - | - | - | - | - | -202.49% | -106.61% |
Net Margin | - | - | - | - | - | -138400.02% | -93391.33% |
Debt / Equity | - | 0.22x | - | - | 1.89x | 0.01x | 0.00x |
Interest Coverage | - | -26.84x | -2.51x | - | -4.47x | -647.82x | -2260.15x |
FCF Conversion | 0.80x | 0.67x | 1.39x | 0.86x | 0.75x | 0.06x | 0.55x |
Related:STSS Dividend History·STSS Revenue History·STSS Price History·STSS P/E History·STSS Financial Ratios·STSS Institutional Holders
STSS SEC Filings & Documents
Sharps Technology, Inc. (STSS) SEC filings — annual & quarterly reports (10-K, 10-Q)
STSS Frequently Asked Questions
Sharps Technology, Inc. (STSS) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Sharps Technology, Inc. (STSS) reported $0.4M in revenue for fiscal year 2025.
Sharps Technology, Inc. (STSS) grew revenue by 0.0% over the past year. Growth has been modest.
Sharps Technology, Inc. (STSS) reported a net loss of $370.7M for fiscal year 2025.
Dividend & Returns
Sharps Technology, Inc. (STSS) has a return on equity (ROE) of -212.1%. Negative ROE indicates the company is unprofitable.
Sharps Technology, Inc. (STSS) had negative free cash flow of $203.0M in fiscal year 2025, likely due to heavy capital investments.